QC
TWST icon

Quadrature Capital’s Twist Bioscience TWST Stock Holding History

Quadrature Capital’s Portfolio TWST Stock Details TWST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-14,998
Closed -$476K – 1866
2025
Q4 		$476K Buy
+14,998
New +$468K ﹤0.01% 706

Other funds holding TWST

Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $12.5B AUM 31.7% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Quadrature Capital's TWST Position: Q1 2026 in Review

Quadrature Capital sold out of Twist Bioscience (TWST) in Q1 2026, closing a stake of 14,998 shares — an estimated $476K sold.

Quadrature Capital first reported a position in TWST in Q4 2025 and held it in 1 quarter. The position peaked at $476K in Q4 2025. 279 funds tracked by Wall St. Rank hold TWST as of Q1 2026.

  • Quadrature Capital reported no remaining Twist Bioscience position as of Q1 2026 after selling out during the quarter.
  • Quadrature Capital sold 14,998 Twist Bioscience shares in Q1 2026, an estimated $476K.
  • Quadrature Capital first reported a position in Twist Bioscience in Q4 2025 and held it in 1 quarter.
  • Quadrature Capital's Twist Bioscience position peaked at $476K in Q4 2025.
  • 279 funds tracked by Wall St. Rank held Twist Bioscience as of Q1 2026.

Based on Quadrature Capital's 13F filing for Q1 2026, filed 15 May 2026.